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Esophageal cancer (EC) is the eighth most aggressive malignancy and its treatment remains a challenge 
due to the lack of biomarkers that can facilitate early detection. EC is identified in two major histological 
forms namely - Adenocarcinoma (EAC) and Squamous cell carcinoma (ESCC), each showing differences 
in the incidence among populations that are geographically separated. Hence the detection of potential 
drug target and biomarkers demands a population-centric understanding of the molecular and cellular 
mechanisms of EC. To provide an adequate impetus to the biomarker discovery for ESCC, which is 
the most prevalent esophageal cancer worldwide, here we have developed ESCC ATLAS, a manually 
curated database that integrates genetic, epigenetic, transcriptomic, and proteomic ESCC-related 
genes from the published literature. It consists of 3475 genes associated to molecular signatures such 
as, altered transcription (2600), altered translation (560), contain copy number variation/structural 
variations (233), SNPs (102), altered DNA methylation (82), Histone modifications (16) and miRNA 
based regulation (261). We provide a user-friendly web interface (http://www.esccatlas.org, freely 
accessible for academic, non-profit users) that facilitates the exploration and the analysis of genes 
among different populations. We anticipate it to be a valuable resource for the population specific 
investigation and biomarker discovery for ESCC.
Esophageal cancer (EC) is eighth most prevalent cancers worldwide with an estimate of 456,000 new cases in 
2012, and the sixth most common cause of death from cancer eliciting 400,000 estimated cases1. Surprisingly in 
China alone, the estimated number of new EC cases and EC caused deaths are recorded as 291,238 and 218,957 
respectively2. EC can be classified as esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma 
(ESCC) according to the type of cells that are involved. EAC mainly occurs in the cells of mucus-secreting glands 
in the esophagus, whereas ESCC affects the thin cells that line the surface of the esophagus3. The incidence of EAC 
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is predominant in the United States, whereas ESCC exhibits a greater geographical diversity in incidence, mortal-
ity and sex ratio especially between Eastern and Asian countries such as Turkey, Iran, Kazakhstan and especially 
northern and central China. More than half of global ESCC cases are recorded in China and accounts for 90% of 
the total EC cases alone2,4–6.
Some of the common and well-known risk factors associated with ESCC in Asian countries are tobacco/
opium smoking, consumption of alcohol and chewing nass or areca nut often mixed with tobacco. In addition 
to these, certain regional food habits are also identified as the potential risk factors associated with the cause of 
ESCC e.g. consumption of beverages such as tea and coffee (linked to amount and temperature), consumption of 
nitrogenous component rich food, boiled yellow butter, and moldy cheese etc7,8. Most often these risk factors are 
strongly associated with sub-populations as they are linked to region-specific lifestyles. For example, although 
the use of tobacco and alcohol are clearly the major risk factors for developing ESCC, they are not accounted 
in Northern China (specifically Anyang region) because of the moderate alcohol consumption in this region9. 
Similarly, tobacco and opium smoking are recognized as the main cause for ESCC in Iranian population10, how-
ever, in Linxian, Shanxi province, China the dietary habits are suspected to be the main causal factor instead of 
smoking11. Several cohort studies have indicated that the obesity is positively associated with EAC, whereas neg-
atively associated with ESCC in the European and USA population12,13. The increase in body mass index (BMI) is 
seen as a protective factor against ESCC in a Chinese cohort study14. This indicates for the existence of a regional 
difference in the risk factors for ESCC. Nevertheless, to date, there are no concrete studies available that can cate-
gorize the risk factors in respect to the regional population groups.
Apart from the lifestyles, genetic variations in the diverse population such as single nucleotide polymor-
phism (SNP)15, and structural variation16, along with epigenetic modifications such as DNA Methylation17–19, 
and Histone modification (HM)20,21, are also known to play a major role in ESCC. Due to the epidemiological 
differences for ESCC between the diversity of a population, there is an increased complexity in the selection of 
population-specific treatment. Hence, in order to get to the roots of ESCC, it becomes important to understand 
the population-specific cause of ESCC in the genomic and proteomic level.
Over the last decade, a number of studies are published on ESCC using genomics and proteomics high 
throughput techniques. Unfortunately, the generated data remain scattered in literature and unavailable as a com-
pendium to the scientific community; An effort to compile this information in past resulted in a manually curated 
“Dragon database of genes involved in esophageal cancer (DDEC)22. However, DDEC is not updated recently. 
Focusing mainly on ESCC, here we have developed a new database called ‘ESCC ATLAS’ that catalogs all the 
genes and related molecular signatures that are involved in ESCC based on an exhaustive literature survey until 
May 2018. As of now the ESCC ATLAS contains 3475-curated gene from 403 unique publications from China 
(205), Japan (74), India (16), Korea (6), Iran (5), America (2), South Africa (4), Italy and Germany representing 
Europe (5) (Numbers in the bracket represents total publications from the corresponding region).
Materials and Methods
Data Collection and Screening. To ensure the highest quality in data collection process, all the entries 
in the ESCC ATLAS were manually collected based on a systematic search of the published literature in the 
PubMed/PubMed Central database. The keywords used to search for the relevant articles were designed consid-
ering the combination of the terminologies related to ESCC and its associated molecular alterations. The arti-
cles were considered eligible only if the reported clinical studies were conducted on human patients and if they 
included the (i) SNP, (ii) Copy number variation (iii) methylation, (iv) miRNA, (v) histone modifications, (vi) 
transcriptomic or (vii) proteomic regulation data (together referred as molecular signature hereafter) relevant to 
the etiology, pathophysiology of ESCC. To maintain the high standards of the collected data, special efforts were 
taken to catalog only those genes or relevant molecular signatures that were shown to have a significant associa-
tion with ESCC by recording the reported statistical test values such as the p-value or fold change. Additionally, 
each entry in ESCC ATLAS was tagged with the cell line information (if reported), sample size, study method 
type and most importantly the population group name by making use of the reported location of the sample 
collection centers (hospital) or the reported population from which the study sample were collected. To fetch 
maximum information possible from each surveyed article, the submitted supplementary data were reviewed 
and included in ESCC ATLAS. Additionally, references cited in the articles were also considered for the data 
extraction when found relevant. The schema for the plan of annotation and biocuration has been shown in Fig. 1.
Database Organization and Web Interface. The web application (front and back end) is developed 
using ExtJS (version 4.3), which facilitates efficient and quick multi-column search. To represent population 
specific data in the world map view, GoogleMap.js (ExtJS built-in plugin) was implemented. All the data in ESCC 
ATLAS were stored and managed using MySQL (version 5.0.51 b). The web services were built using Apache 
(version 2.2.17) and PHP (version 5.2.14) as server side scripting language. The whole system is hosted under Red 
Hat Enterprise Linux 5 environment.
Population specific ESCC incidence and ESCC ATLAS entries. To get an overview of the worldwide 
population specific ESCC incidence, we collected the age-standardized rate of ESCC incidence available from 
GLOBOCAN 2012, and compared the number of collected molecular signatures for different populations in our 
survey.
Functional enrichment analysis. Gene Ontology (GO) analysis was performed across all the three domains, 
Biological process, Molecular Function, and Cellular component. The populations analyzed were: Indian, Chinese, 
Japanese, Iranian, Korean and South African. The GO annotations associated to all 3475 genes from ESCC ATLAS 
were downloaded using biomaRt Bioconductor package in R (Ensembl release 89)23. An in-house R script was used 
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to identify the overrepresented GO terms by comparing the proportion of genes annotated to a specific GO term in 
each population (test gene group) against the total protein-coding genes in human genome (background gene group). 
The prop.test() function in R was implemented for the comparison, which calculates a chi-squared statistic to test the 
null hypothesis that the proportion of test and the background set of genes annotated to a specific GO terms are the 
same. Since multiple comparisons are performed in this analysis, the p-values thus obtained are adjusted to narrow 
down the chances of false discoveries using the False Discovery Rate method24,25 implemented in the p.adjust func-
tion in R. Additionally, for each of the GO term an enrichment score (ES) is calculated, where ES is, (Total number 
of annotated test genes/Total number of annotated background genes) * 100.
The overrepresented GO terms among the genes corresponding to each population were then selected based 
on the p-value cut off of <0.01 and summarized as scatterplots using REVIGO26. The enriched GO terms and 
their corresponding ES were supplied to the to REVIGO web server (http://revigo.irb.hr/). The option concerning 
Screening of research papers for molecular alterations in ESCC tissues/cell lines
 compared to their adjacent normal or non-neoplastic epithelial cell lines
Manual biocuration of selected  
reserach articles after screening
Extensive literature search on Esophageal Squamous Cell Carcinoma
(ESCC) using relevant terminology search criteria
DNA
Molecular Alterations
mRNA miRNA Protein
· Regulation / Expression level
· Fold change 
· Experimental method
· Statistical significance (p-value)
· Hospital/Sample collection centre
· Region/Population
· PubMed citation
ESCC ATLAS
SNP, CNV, methylation Expression / Regulation
Expression / 
Expression / Regulation
GMap ID Assignment
Figure 1. Schema for annotation of different types of molecular alterations in esophageal squamous cell 
carcinoma. The research articles published on esophageal squamous cell carcinoma (ESCC) are screened to 
filter the differentially expressed molecules at DNA, mRNA, miRNA and protein levels in ESCC tissues/cell 
lines as compared with their normal cell line or adjacent normal epithelia. The screened articles fulfilling the 
criteria described in the schema are manually curated to catalog the molecular alternations at DNA, mRNA, 
miRNA, and protein level. The information pertaining to ESCC and gene regulation status, the experimental 
approach used, analysis design, region of sample collection and along with the PubMed citation is provided for 
each molecule. The molecules are provided with external link to other database like OMIM, HPRD, HGNC and 
Ensembl to additional information about the molecule.
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semantic similarity measure was set to SimRel and the database for GO term size was set to Homo sapiens. The 
REVIGO checks for the redundancy of the GO terms represented by bubbles into a two-dimensional space by 
applying the multidimensional scaling to a matrix of GO terms semantic similarities.
Protein-protein interactions. To get further insights on the important genes from the GO enrich-
ment analysis, we looked for protein-protein interactions (PPI) networks using the PEPPER (Protein complex 
Expansion using Protein-Protein intERaction networks) application in Cytoscape27. PEPPER identifies the mean-
ingful pathways/complexes as densely connected sub-networks from seeds (lists of input protein coding genes) 
using the information from protein interactions available in BioGRID database (in this analysis)28. PEPPER 
includes a topological and function-based post-processing pipeline for ranking the newly added proteins (expan-
sions) according to their relevance to the seeds. The expansions are scored according to their co-occurrence with 
the seeds based on their impact on the overall connectivity of the subnetwork. The default parameter settings were 
used for the PEPPER algorithm. The output PPI network view were manually customized by hiding or showing 
the proteins/edges that were added by PEPPER algorithm to make it more readable in respect to the seeds. The 
interaction networks between the expansions are not shown.
Statistical Analysis. The studies took into consideration for annotation purpose were considered only if a 
given molecule had either 2-fold up or downregulation, and/or differential regulation with p < 0.05. Since, the 
data included in the study is derived from the previously published studied by the scientist from all around the 
world, we applied these two-criteria only to avoid any tweaking of the data.
“Ethics approval” and consent to participate. The study does not involved human, animal or cell lines 
as a material for experimental purpose. The data involved in the study is curated exclusively using published 
studies available through PubMed or PubMed Central (PMC) or Google search based research articles or sources.
Results
Data Summary. We presented the schema for collection of the data for this study in Fig. 1. We collected a 
total of 3475 non-redundant ESCC associated genes that fulfills the eligibility criteria to be included in ESCC 
ATLAS. The total number of published research articles referred for the data extraction for each molecular sig-
nature is shown in Dataset 1.
Based on our literature survey and the ESCC incidence data available from GLOBOCAN 2012, we identified 
that despite of a very high incidence rate of ESCC among Iranian and South African population only few pub-
lished studies are available focusing on these population that could aid the ESCC investigation and biomarker 
discovery (Fig. 2).
All the data in ESCC ATLAS is freely accessible via user-friendly web interface at http://www.esccatlas.org. 
Additionally, ESCC ATLAS also provides an option for the bulk data download as flat files which is useful for 
other downstream analysis.
Collection of population specific ESCC associated molecular signatures. Genes involved in the 
transcriptomic and proteomic regulation of ESCC. We found majority of the transcriptomic and proteomic signa-
tures associated to ESCC were uniquely identified for different populations suggesting a population specific ESCC 
etiology that could be linked to different lifestyles and environmental exposures (Fig. 3A and B).
Figure 2. Population specific ESCC incidence and ESCC ATLAS entries. The observance of ESCC incidence 
was higher among Iranian and South African population, but the number of investigations focusing on these 
populations are very low. Hence, there are very few known ESCC associated molecular signatures. Here, 
x-axis indicates the total number of published articles focusing on specific population (that were surveyed and 
recorded in ESCC ATLAS) and the y-axis indicates the age-standardized rate (ASR) of ESCC incidence available 
from GLOBOCAN 2012. The size of scatter plots represents the total number of recorded molecular signatures 
to be associated with ESCC from the surveyed article.
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Transcriptome and proteome landscape of ESCC in global population. A total of 2592 unique transcriptomic sig-
natures (genes) were curated. The expression status of these genes was studied and their distribution in different 
populations was analyzed. Gene regulation differences between populations with respect to the biological sample 
used to conduct the study was analyzed using transcriptomic data. It was found that the regulation remained con-
sistent between populations in the same biological material. 17 genes were found where the biological material 
used differed, however, the regulation status remained consistent between populations. Out of these, only one 
gene, glutathione peroxidase 3 (GPX3) showed irregularities or difference in regulation between populations in 
different biological materials. GPX3 transcriptomic data was recorded for Chinese and Indian populations. Its 
expression was found to be downregulated in cell line samples of Chinese population, whereas in tissue samples of 
the same population it was found to be upregulated. Proteomic data was also analyzed to check for any inconsist-
encies with respect to biological material. For GPX3, expression regulation and status was found to be consistent 
between all population levels in proteomics in same or different biological materials.
An expression of GPX3 was downregulated in ESCC as compared with normal samples29,30. Furthermore, 
GPX3 methylation was significantly higher in ESCC as compared to normal tissue samples31.
GPX3 was among an 8-gene signature panel that had been used for predicting the status (normal versus tumor) 
of gastric tissues with an accuracy of >96%. As an outcome of promoter hypermethylation, GPX3 was down regu-
lated in gastric cancer32. Furthermore, an in vitro study an association between GPX3 and lymph node metastasis 
was found in gastric cancer upon downregulation of GPX3 expression and promoter hypermethylation33.
In a previous study, GPX3 was methylated in prostate cancer34 and an in vitro overexpression of GPX3 in prostate 
cancer cell lines could suppress formation of colonies as well as growth of cells in an anchorage-independent manner, 
and reduce the invasiness of the prostate cancer cells indicates the tumor suppressor activity of GPX335. In case of breast 
cancer as well GPX3 was downregulated at mRNA as well as at protein levels in the inflammatory breast cancer as com-
pared with non-IBC. Hypermethylation of GPX3 promoter was observed in breast cancer, but not in normal tissues36.
Population levels for transcriptomic data were found to be the following: Chinese, Japanese, and Indian. A 
total of 2060 genes in the Indian Population, 977 in the Chinese population, 203 genes in the Japanese population, 
and 163 ESCC-related genes were associated with the unknown/mixed population. A study of common and 
unique genes between combinations of different populations showed that the Chinese and Indian populations 
have the highest number of genes common between them. Only 1 gene (CSK2) was found to be common between 
all four populations, and was found to be upregulated.
Similarly, genes curated for proteomic data were also compared. Population levels were: Indian, Chinese and 
Japanese. The Indian population (293) had the highest number of genes curated, followed by Chinese (31) and 
Japanese (13). An analysis of common and unique genes between the populations revealed that only 3 genes 
(CDH1, EZR, YBX1) were found common between Indian and Chinese populations.
Among these genes E-cadherin (CDH1) is a tumor suppressor involved in epithelial cell-cell interactions. It’s 
a calcium-dependent cell adhesion protein involved in tumor invasiveness. CDH1 has been reported to be hyper-
methylated in previous studies on ESCC37–42, and downregulation and/or loss of CDH1 has been documented in 
ESCC40,41. Interestingly, there was lack of association between -160C/A SNP of CDH1 and ESCC development43.
Ezrin is a cytoplasmic peripheral membranous protein, which is a member of the ezrin/radixin/moesin (ERM) 
family of proteins linking plasma membrane to F-actin cytoskeleton. Expression of EZR has been associated with 
invasiveness and lymph node metastasis of ESCC44,45. Translocation of EZR protein from plasma membrane to 
cytoplasm was observed in ESCC cells46. The knockdown inhibition of EZR led to decrease in growth, adhesion, 
and invasiveness of the ESCC cells in vitro and ability to induce tumorigenesis in in vivo conditions47.
Y-box binding protein 1 (YB-1 or YBX1) is an RNA and DNA binding factor. YBX1 expression had been 
observed not only in endothelial cells but in esophageal cancer cells as well. YBX1 gene was upregulated and 
overexpressed in ESCC as compared with normal samples48,49. An elevated level of YBX1 protein associated with 
higher recurrence & lower survival in ESCC patients49.
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Figure 3. Distribution of molecular signatures vs. number of curated articles or number of genes across 
different populations. It shows statistics of (A) distribution of molecular signature (transcriptomics, proteomics, 
structural variation, SNV, miRNA, methylation, and histone modification) vs. number of curated research 
articles in different populations (coded with different colors) and (B) distribution of molecular signature 
(trasncriptomics, proteomics, structural variation, SNV, miRNA, methylation, and histone modification) vs. 
number of genes observed or curated from different populations (coded with different colors).
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Among another set of genes, we found two metalloproteinases (MMPs) genes (MMP2 and MMP3). These 
found in between Chinese and Japanese populations. These Zinc dependent MMPs including MMP2, MMP3, 
and MMP9 along with serine proteases play an important role in ESCC pathogenesis50,51. An overexpression of 
MMP2 has been reported in ESCC tissues as compared to adjacent normal epithelia52, and MMP3 SNP (MMP3 - 
1612 5A/6A) polymorphism was significantly associated with susceptibility to ESCC means ESCC subjects bear-
ing 5A allele were more prone of getting ESCC as compared with 6A allele50.
There was not even a single found common between the Indian and Japanese populations, and same scenario 
was observed when we compared Indian, Chinese and Japanese populations.
Upon careful study of derived transcriptomic and proteomic population data, it is found that the highest 
number of recorded cases was found in the Indian population, followed by the Chinese and finally, the Japanese 
population. A list of complete and unique genes is provided in the supplementary material. The Venn diagram 
package from CRAN repository was used to create a graphical representation depicting common and unique gene 
distribution between different populations at the transcriptomic and proteomic levels (Fig. 4A and B).
SNPs in ESCC. In risk variants survey for ESCC, we found 85 genes harboring one or more risk variants in 
Chinese, 8 in Iranian, 5 in Indian, 4 in South African, 3 in European, and 1 in Japanese populations but none in 
Korean or unknown/mixed populations. Examining these population specific genes with that of transcriptome 
and proteome data, we could determine only 1 of the genes (PADI4) in Chinese (19 in transcriptome, 1 in pro-
teome), but none in Japanese, Indian (4 in transcriptome), South Africa, European and Iranian populations that 
link with both altered transcriptomic and proteomic status. However, when we studied the transcriptomics and 
proteomics of global populations irrespective of population specificity in consideration, we could identify 8 genes: 
GSTP1, PADI4, CCND1, FEN1, ADH1A, CRNN and S100A14 (40 in transcriptome; 11 in proteome) that were 
linked with both altered transcriptomic and proteomic status among 95 total unique genes harboring one or more 
risk variants (Supplementary Dataset # 2). Among these genes, PADI4 encode for protein arginine deiminase 4 
catalyzes the hydrolytic deimination of arginine residues to produce citrulline and ammonia. Elevation of PADI4 
was observed at mRNA as well as at protein levels in ESCC as well as in EAD53. It is an intracellular protein but 
it had been detected in pIasma samples of the cancer patients as well. In SNPs based study on PADI4, rs2240337 
G > A SNP was found to be significantly associated with decreased risk of ESCC54. Earlier findings in SNPs study 
on PADI4 in EC reported rs10437048 and rs41265997 were significantly associated with decreased and increased 
risk of EC, respectively53.
Methylation in ESCC. We identified 51 genes with altered methylation status for Chinese (hyper: 50, hypo: 1), 
22 for Japanese (hyper: 22, hypo: 0), 8 for Korean (hyper: 8, hypo: 0), 2 for Indian (hyper: 2, hypo: 0), and 2 for 
Iranian (hyper: 2, hypo: 0) populations. Examining these population specific genes (altered methylation) with that 
of transcriptome and proteome data, we could determine only 3 of the genes (GADD45A, UPK1A, and C2orf40) 
in Chinese (15 in transcriptome, 3 in proteome), 1 (TIMP3) in Japanese (3 in transcriptome, 1 in proteome), 
1 (CLDN4) in Korean (4 in transcriptome, 1 in proteome), but none in Indian and Iranian populations that 
were linked with altered transcriptomic and proteomic status. However, when examined with transcriptomics 
and proteomics of global populations without specific populations into consideration, we could identify 16 of 
them (44 in transcriptome; 24 in proteome) were linked with both altered transcriptomic and proteomic status 
among 95 total unique methylated genes (hyper: 85; hypo: 4; unknown status: 6) (Dataset # 2).
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Figure 4. Distribution and overlapping of Transcriptomic and Proteomic data. Venn diagram representing 
distribution of (A) transcriptomic, and (B) proteomic evidences between different populations and indicating 
unique and common genes involved in etiology of ESCC between the different populations. We had only 
CLDN4 gene with Transcriptomic evidences for Korean population, the same gene also found in Indian 
population. However, for better representation, we did not plot Korean population in (A).
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Histone modification in ESCC. We could find 6 genes with altered histone modifications for Chinese 
(Acetylation 1; phosphorylation 6, deacetylation 1, gene PTK6 has both Deacetylation, Phosphorylation evi-
dence), 4 for Japanese (Acetylation 3; phosphorylation 1, deacetylation 0), 1 for Korean (Acetylation 0; phos-
phorylation 1, deacetylation 0), and none for Indian and Iranian populations (no HM studies in these two). 
Examining these population specific genes (altered HM) with that of transcriptome and proteome data, we could 
determine only 3 of the genes in Chinese (0 in transcriptome, 3 in proteome), 1 in Japanese (0 in transcriptome, 
1 in proteome), 1 in Korean (0 in transcriptome, 1 in proteome), link with altered proteomic status. However, 
none of the population specific gene could link to transcriptomic changes. Upon examining all the 18 unique HM 
altered genes (18; Acetylation 6; phosphorylation 11, deacetylation 2) with transcriptomics and proteomics of 
global populations without specific populations into consideration, we could identify 5 (PTK6, KLF4, MAGEA3, 
PIK3C2B, WDHD1) of them (5 in transcriptome; 16 in proteome) were linked with both altered transcriptomic 
and proteomic status (Dataset # 2).
Structural variation in ESCC. We found 92 (amplification: 35, Deletion: 6, LOH: 52) unique genes overlapping/
published on the structural variations regions from so far published literature in Chinese, 91 (Amplification: 43, 
Deletion: 47, loss of heterozygosity i.e. LOH: 1) in Indian, 25 (Amplification: 22, Deletion: 13) in South African 
and 2 (Amplification: 1, LOH: 1) in Japanese populations. Examining these population specific genes with that 
of transcriptome and proteome data, we could determine only 4 of the genes (CCND1, CTTN, FAS, CDC25B) 
in Chinese (60 in transcriptome; 4 in proteome), 3 (20 in transcriptome; 3 in proteome) of the genes (GSN, 
KRT13, COL12A1) in Indian, but none in SA and Japanese populations, link with both altered transcriptomic 
and proteomic status. However, when examined with transcriptomics and proteomics of global populations 
without specific populations into consideration, we could identify 17 (CCND1, CTTN, FAS, CDC25B, KRT13, 
COL12A1, GSR, IL1RN, PDCD4, TP63, SERPINH1, PSMA6, CFL1, GNPNAT1, GSTP1, PRKCI) (Amplification: 
12, Deletion:1, LOH: 4) of them were linked with both altered transcriptomic and proteomic status among 304 
total unique genes published on structural variations so far (refer supplementary data).
miRs in ESCC. Each collected miRNA entries in ESCC ATLAS were mapped to their target genes by making use 
of the miRTarBase (a resource for experimentally validated miRNA targets) and www.microRNA.org (resource 
for predicted targets using miRanda algorithm). Currently, we have curated a total of 184 unique miRNAs in 
our database, out of which 61 miRNAs were mapped to their experimentally validated target genes listed in 
ESCC ATLAS. The miRNA entries were also checked for one to many mappings to their target genes, as a single 
miRNA can have more than one target gene(s). For example, from our curated list of miRNAs, hsa-miR-107, 
hsa-miR-326, hsa-miR-375 and hsa-miR-320a have multiple target genes.
A total of 184 miRNAs were studied, some of those were repetitive due to the redundancy of their respective 
target genes. The number of target genes for these cannot be accurately estimated due to the large number of 
target genes for a single miRNA species. The populations included in the study included Chinese, Japanese, and 
Iranian. We identified uniquely, 38 miRNA linked to the Chinese population, 25 in the Japanese Population, 1 in 
the Iranian and 2 in the unknown/mixed population. Upon comparing miRNA target gene regulation with that 
of transcriptomic and proteomic regulation data, we found two genes to show consistency in regulation status 
between miRNA transcriptomic and proteomic data. In the Chinese population, hsa-miR-451a was found to be 
downregulated. It’s target gene MMP-9 was found to be upregulated in the Chinese population, in both transcrip-
tomic and proteomic datasets. Similarly, another gene FSCN1 had upregulated transcriptomic and proteomic 
status, is a target gene for hsa-miR-133b, which was found to be downregulated in the Chinese population. This 
corroborates the miRNA-gene-silencing mechanism, which is reflected in this analysis.
Population-wide GO analysis. Several GO terms (with respect to Biological process, Molecular function and 
Cellular component) found through analysis, were common/overlapping and unique between populations such 
as Chinese, Indian, Japanese, South African and unknown/mixed (Fig. 5A,B and C). The list of all overrepre-
sented GO terms and the number of genes associated to them are shown in the Dataset # 3.
Certain over-represented GO terms were found to overlap between populations (Fig. 5), for e.g. the GO 
terms “negative regulation of apoptosis”(11% of all test genes), “positive regulation of cell proliferation”(10% of 
all test genes) which are the hallmarks of cancer, were found to be over-represented in the Chinese, Indian and 
unknown/mixed populations.
The GO term “positive regulation of cell proliferation” was found to exist in unknown/mixed, Chinese and 
Indian population. Among the test genes, we found that STAT3, CCND1, FGFR2 were of significance when com-
pared to their regulation status in our curated data. FGFR2 was observed as overexpressed in the unknown/mixed 
population. In the Chinese population, STAT3 is commonly found overexpressed in ESCC and is associated with 
invasion of ESCCs55. Amplification and overexpression of CCND1 was found in ESCC in the North-eastern 
Chinese population56. Lastly, frequent gene amplification of FGFR2 is found in ESCC specimens57. This suggests 
that upregulation of STAT3, CCND1 and FGFR2 derails positive regulation of cell proliferation in ESCC. To get 
further insight into PPI network for STAT3, CCND1 and FGFR2, we used PEPPER to identify only few direct 
interactions within our input list of proteins (seeds, purple and green nodes) (Fig. 6). However the proteins (expan-
sions) added by PEPPER algorithm constitutes a complex interaction network that connects together almost all of 
our input protein coding genes. The predicted network provides a global aspect for PPI of the key protein coding 
genes that could be involved in ESCC e.g STAT3 (Signal Transducer and Activator of Transcription 3), which is 
used as the bait protein in PEPPER PPI analysis clearly shows direct interactions between FGFR2 (Fibroblast 
growth factor receptors) and CCND1 (Cyclin D1). Indeed, oncogenic FGFR amplification is seen as a require-
ment that results in ectopic activation of the STAT3 transcriptional response58. And the constitutive activation of 
STAT3 and CCND1 overexpression is accounted for the proliferation, migration and invasion in gastric cancer 
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cells59. Based on the interaction networks considering the expansion proteins we could observe STAT3 interacts 
with PML (Promyelocytic Leukemia Protein) and HDACs (Histone Deacetylase proteins). Indeed it is known that 
the acetylation of STAT3 and its subsequent binding with HDAC1 is involved in control of its nucleocytoplasmic 
distribution in Human hepatoblastoma HepG2 cells60. Similarly, PML is known to modulate interleukin (IL)-
6-induced STAT3 activation and hepatoma cell growth by interacting with HDAC361. RELA (NFκB) is known 
to be constitutively active in many cancers where it up-regulates anti-apoptotic and other oncogenic genes and 
here we observe a direct interaction between STAT3 and RELA. Studies have shown that STAT3 are involved in 
prolonging RELA nuclear retention through EP300 (acetyltransferase p300-mediated) RELA acetylation, thereby 
interfering with RELA nuclear export62. In summary, based on the PPI network analysis we obtained a global 
aspect of interaction networks between the candidate genes shortlisted genes from the GO enrichment analysis 
and other key protein-coding genes that could be involved in ESCC biogenesis.
Similarly, the GO term “negative regulation of apoptosis”, was found associated with the enriched term in 
the Chinese and the unknown/mixed population. It is known that CASP3 is involved in the apoptosis path-
way and certain genetic variants of the gene confer susceptibility to ESCC. CASP3 829A > C (rs4647602) gen-
otype is found to be associated with risk of ESCC. Variant rs4647602 (CC genotype) significantly reduced the 
Figure 5. Data analysis for population specific overrepresented GO terms. Data analysis for population specific 
overrepresented GO terms corresponding to (A) biological process, (B) molecular function and (C) cellular 
component. In the scatterplot the semantically similar GO terms remain close together in cluster and are labeled 
with the representative GO term with the highest enrichment score. The bubbles corresponding to common 
GO terms between different populations are adjusted in two-dimensional space by adding or subtracting 0.15 
semantic space units. The bubble size indicates the frequency of GO term in the underlying GOA database.
Figure 6. Protein-protein interactions. Hexagonal red nodes correspond to proteins that were added by 
PEPPER algorithm (expansions), the red shades of the hexagonal nodes correspond to the scores of relevance 
computed in the post-processing step. The purple square represents a protein of interest (bait, which is STAT3 
in this case). The rounded green nodes represent the list of input proteins (preys). The green edges represent the 
initial interactions between the seeds (bait and preys). The red, dark and light blue edges are used to represent 
the interaction between the seeds and the expansions.
www.nature.com/scientificreports/
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transcriptional activity of caspase-3 and it was associated with an increased risk of ESCC in the Chinese popula-
tion57. Furthermore, CASP3 is downregulated in the Chinese population when a comparison was made between 
normal versus basal cell hyperplasia63, but upregulated in ESCC as compared with adjacent normal tissues64.
Discernibly, some GO terms that may be of significance were unique for certain populations. For example, the 
term “cell differentiation” was uniquely associated with the unknown/mixed population. One of the genes, GRB2 
that contributed to enrich the term, is found overexpressed with lymph node metastasis and poor prognosis in 
ESCC where cellular differentiation could be an influencing factor65. Evidently, from our curated data, we find 
that GRB2 is found to be upregulated in the unknown/mixed population.
Distinctly, the GO term “DNA repair” was found only in the Chinese population with 11% of test genes asso-
ciated with this term. On comparing the genes for which this term was enriched, we found that some of them 
showed interesting expression levels in correlation with ESCC and literature. Curated SNP data shows that the 
polymorphisms found in the genes XRCC1, POLQ, FANCG, FEN1, SMUG1 were directly associated with risk of 
ESCC in the Chinese population66,67. These genes were also found in our GO analysis results for the term DNA 
repair. Expression status of some of these genes namely, XRCC1, FANCG and FEN1 was found to be upregulated 
in curated gene expression data. Therefore, one may infer a relation between polymorphisms in DNA repair genes 
that may lead to ESCC development and progression.
In the Indian population, 20% of the test genes were associated with the GO term “oxidation-reduction pro-
cess”. The genes enriched for this term belong to family of cytochrome p450 enzymes (CYP1A1, CYP24A1, 
CYP26A1, CYP27B1, CYP2C18, CYP2C9, CYP2E1, CYP2J2, CYP3A4, CYP4B1, CYP4F12, CYP4F8, CYP4X1). 
Interestingly, all the genes found to be downregulated in the Indian population except CYP24A1, CYP26A1 and 
CYP27B1. Polymorphisms found in CYP2E1 and CYP1A1 are risk factors for development of ESCC68,69.
Another interesting observation found in the unknown/mixed population is that of oncogene DJ-1 (PARK7). 
Although out of 94 test genes, only DJ-1 was associated with the GO term “negative regulation of TRAIL-activated 
signaling pathway”, it is found in our curated data and upregulated in the unknown/mixed population70 (Dataset # 2). 
The oncogene, DJ-1 inhibits TRAIL-activated apoptosis pathway by blocking pro-caspase 871. Incidentally, CASP8 
was found to be downregulated in ESCC ATLAS in Chinese population. Overall, DJ1 plays an important role in 
transformation and ESCC progression, which suggests that DJ1 could be a prognostic marker for ESCC.
Alcohol consumption is widely known to be a risk factor for ESCC. In the Chinese population, GO analysis 
results showed enrichment for the terms “ethanol oxidation” and “alcohol metabolism”. Six of the test genes were 
associated with the former term and 3 of the test genes for the latter. Extensive literature review reveals that the 
alcohol metabolism pathway has two steps - ethanol oxidation, i.e. conversion of ethanol to acetaldehyde; and 
elimination of acetaldehyde from the body by conversion to acetate and finally to water and carbon dioxide. 
The first step carried out by involvement of two enzymes - Alcohol dehydrogenases (ADH1B) and cytochrome 
P450 (CYP2E1) enzymes. The second step is catalyzed by aldehyde dehydrogenase (ALDH2)72, it is found that 
variants of these genes affect the catalytic rate of the reaction in both steps73. An SNP found in the ADH1B gene 
(rs1229984) that replaces arginine with Histidine at the 48th position makes the enzyme catalytically faster72. The 
heterozygous (ADH1B Arg/His) and homozygous (ADH1B His/His) variants of the gene possess higher catalytic 
activity and are faster in converting ethanol to acetaldehyde compared to the wild type (ADH1B Arg/Arg) allele. 
It is these variants that are associated with risk of ESCC. Acetaldehyde is a known carcinogen. It’s accumulation in 
the body due to its rapid production by the variant versions of the ADH1B enzyme leads to acetaldehyde carcino-
genesis. This SNP is also found curated in our SNP dataset in the Chinese population, along with an SNP found in 
ALDH2 (rs671). The variant alleles of ALDH2 render it inactive, thereby promoting acetaldehyde accumulation 
and carcinogenesis in ESCC. With numerous examples of GO based analysis shows that ESCC ATLAS provided 
in-depth analysis on molecules differentially regulated between ESCC versus normal across different population.
Metabolism related aspects also contribute to malignancies including EC. In recent years, relations have been 
established between EC types and metabolism associated parameters such as body mass index, and blood pres-
sure. A positive association was found between BMI and EAC, and a negatively association was found with risk of 
ESCC12. Obesity acts as a risk factor for BE as well as for EAC74. The underlying mechanisms behind association 
or role of obesity with ECs must be further explored in light of molecules such as leptin, adiponectin, estrogen 
and obesity related genes75. Interestingly adipose tissue has the ability to influences the development of tumor, 
which is dependent on secretor product adipokines and cytokines secreted by adipocytes and inflammatory cells, 
respectively76. An abundant supply of lipids by the adipocytes in tumor-microenvironment, supports progression 
and uncontrolled growth of the tumor77.
A good number of studies on single nucleotide polymorphisms (SNPs) based study was carried out on obesity 
related genes to find out an association with EAC, adenocarcinoma of esophagogastric junction, and ESCC, but 
there was no association found EGJAC or ESCC78. Three SNPs in NER pathway particularly the variant alleles 
of the XPD Lys751Gln, ERCC1 8092C/A and ERCC1 118C/T were associated with an increased risk of EAC79.
Overall, we found >600 common genes for Indian and Chinese population. The details of the genes have 
been provided in Dataset # 4. This large set of genes includes extracellular matrix related genes such as MMP1, 
MMP3, MPP7, MMP9, MMP10, MMP11, MMP12, MMP13, and MMP14. Some of the interesting genes include 
DUSP5 (Dual Specificity Phosphatase 5), which codes for DUSP5 protein. DUSP5 was found as downregulated in 
achalasia (a condition in which lack of relaxation of the lower esophageal sphincter occurs, act as a risk factor for 
ESCC, and 6% of the total achalasia subjects develop ESCC)80. Furthermore, DUSP5 was downregulated in ESCC 
as compared with adjacent normal in Indian and Chinese studies30,81,82. In addition to different molecules con-
tributing to ESCC tumorigenesis in Indian and Chinese population, there is life style mainly diet pattern (Chinese 
and Indian particularly South Indians either prefers to have spicy food and/or consumption of pickled vegetables, 
and intake of alcohol and tobacco). In addition to these, to establish what are common factors among Chinese 
and India population, a comparative analysis is required to establish common pre-disposing and risk factors 
(achalasia, atrophic gastritis83, an infection by cytotoxin-associated gene A (CagA)-positive Helicobacter pylori84, 
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injury to the esophagus, consumption of pickled vegetables, Plummer Vinson syndrome, Chaggas-associated 
mega-esophagus, and a history of certain head and neck cancers)85.
A quick search for the genes and their molecular signatures associated to ESCC in different population groups 
could be easily seen in 3 steps as shown in Fig. 7. Various useful external links are also embedded in the search 
results, for example, gene IDs, symbols, and gene alias from HUGO Gene Nomenclature Committee (HGNC), 
human protein reference database (HPRD) and Ensembl databases. The gene function and associated gene ontol-
ogies could also easily browsed with the links to GO database. A PubMed link to the reference research article is 
also made available. Further, upon entering the gene symbol for gene of interest e.g. osteopontin (SPP1) (Fig. 6), 
details about population specific, mRNA or protein level expression can be seen and additional information about 
the molecule is possible to explore by hitting external links like HGNC, HPRD or OMIM.
Discussions
The “Omics” driven projects produced enormous amount of data. One of the biggest challenges faced by the sci-
entific community was ‘how to handle and present this gigantic amount of data in a user friendly way’. In order to 
overcome, a number of cancer specific database developed including ONCOMINE (a cancer microarray database 
and web-based data-mining platform)86, pancreatic cancer87–89, Breast Cancer Database for breast cancer90,91, 
Dragon Database of Genes associated with Prostate Cancer92, Renal cancer gene database on renal cancer93, 
HLungDB: an integrated database of human lung cancer research14, Cervical Cancer Database on cervical can-
cer94, curatedOvarianDat on Clinically annotated data for the ovarian cancer transcriptome95, and Osteosarcoma, 
a database of osteosarcoma-associated genes96. Furthermore, there were efforts to make repository to have pepti-
dome (a pool of peptides) detected in cancer-associated biofluids97.
In an earlier effort, DDEC was developed where a total number of 529 genes were reported. The database excluded 
the data derived from high-throughput microarray studies leaving an enormous amount of data not curated for 
ESCC22. Hence, with an aim of providing a central repository for scientific community in the area of ESCC, we 
developed ESCC ATLAS, a database system that focused on providing an in-depth resource of gene, miRNA and 
protein information and their relationships to ESCC overall and in a population specific manner. We made efforts to 
make ESCC ATLAS as a repository to have biocurated data for ESCC from low as well as high-throughput studies.
In the last 5 yrs, large amounts of data have been collected for making ESCC ATLAS. Information on ESCC 
data was obtained from the PubMed, PubMed central, google search engine. Genes, miRNAs, proteins, gene 
promoters, transcription factors, transcription factor-binding sites and the SNPs related to ESCC cancer have 
Figure 7. (A) screenshot of the primary information page for OPN/Osteopontin (gene/protein in ESCCDb. 
The query, browse and results tabs/pages for Osteopontin protein are shown (B) The molecule page for OPN 
with the DNA, mRNA, miRNA and protein level alterations, level of regulation, experimental approach used, 
PubMed citation and external links to publicly available resources. The figure was created using software Adobe 
Illustrator CS5 Version 15.0.0.
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been collected and integrated into this system. The data collected in ESCC ATLAS was not only cataloged, but 
also exploited to gather regional disparity with ESCC research activities and molecular signatures discovered 
so far. Interestingly, cross-comparison of incidence of ESCC, number of molecular studies and total molecular 
signature identified between different populations suggests that despite high incidence of ESCC in Iranian and 
South African population low number of molecular studies lead to low number of molecular signatures iden-
tification. The 3475 genes/proteins in ESCC ATLAS are integrated in a way that investigator can rapidly query 
whether a gene or protein is found in human ESCC, and other detailed ESCC-related information about this 
gene. User-friendly query interfaces have made all the features of ESCC ATLAS easily accessible. ESCC ATLAS 
provides a comprehensive resource for human ESCC research. We believe that ESCC ATLAS will be particularly 
interesting to the life science community and will greatly facilitate cancer biologists’ mission of unraveling the 
pathogenesis of ESCC.
To extrapolate curated information in ESCC ATLAS, we created navigational links to other resources such 
as NCBI Entrez gene98, HGNC99, OMIM100, HPRD101,102, Ensemble103, KEGG104, WikiPathways105, GO106, miR-
Base107, and DGV108.
Strikingly, evaluation of transcriptome and proteome signatures among all populations suggested that from 
transcriptome only CSK2 found to be common with upregulation status in Chinese, Japanese, and Indian popu-
lations, whereas from proteome, genes CDH1, EZR, and YBX1 were found common between Indian and Chinese 
populations and genes MMP2, and MMP3 between Chinese and Japanese populations. This clearly exhibits, a 
significant number of population specific genes regulation involved in the etiology of ESCC between different 
populations.
Consolidation of GO analysis results with regulation of molecular signatures captured through our cura-
tion process, corroborate mechanism that drive progression of ESCC. The GO term “positive regulation of cell 
proliferation” (enriched from STAT3, CCND1, FGFR2) was found to exist in, Chinese and Indian population. 
Similarly, the GO term “negative regulation of apoptosis”, (enriched from CASP3) was found associated with 
Chinese population.
Distinctly, the term “cell differentiation” (GRB2) was uniquely associated with the unknown/mixed popu-
lation, the term “DNA repair” (enriched from XRCC1, POLQ, FANCG, FEN1, SMUG1) was found only in the 
Chinese population, the GO term “oxidation-reduction process” (enriched from family of cytochrome p450 
enzymes) were associated Indian population, and “negative regulation of TRAIL-activated signaling pathway” 
(enriched by oncogene DJ-1) in unknown/mixed population. Importantly, alcohol consumption is widely known 
to be a risk factor for ESCC, GO analysis results showed enrichment for the terms “ethanol oxidation” and “alco-
hol metabolism” in the Chinese population (found in Iranian as well).
Furthermore, ESCC ATLAS showed that variation between populations for a single molecule/gene are there as 
e.g. KRT17 gene is upregulated in 7 studies on Chinese (06) and North Indian (01) population, but downregulated 
in study on North-East Indian population109. The further collection data in ESCC ATLAS will allow researchers to 
study and compare the variation between the different populations. The information and link for the genes/pro-
teins altered in ESCC are provided which allows researchers to know whether a particular molecule bears surface 
expression and secretory in nature to detect it in biological fluids using assays like ELISA assay.
Over the course of time, watching the approaches undertaken in human genomics, now research commu-
nity is urging for an epoch with radical revision of human genomics110. In nutshell, we have biocurated the 
literature-derived data from studies on ESCC in ESCC ATLAS covering from DNA, mRNA, miRNA to protein 
levels. ESCC ATLAS provides scientific community with an easy access to different aspects of information regard-
ing molecules driving ESCC carcinogenesis. In the future, we will incorporate more different kinds of genomics, 
proteomics, metabolomics, and pharmacogenomics based data in further updates to ESCC ATLAS, so that the 
database will continue to be an informative and valuable source ESCC associated molecular alterations and serve 
as a key repository for basic and translational research on ESCC.
Conclusions
In conclusion, here we present ESCC ATLAS, an on-line database through which users can perform search 
for close to 3500 differentially regulated molecular alterations associated with ESCC tissues or cell lines. ESCC 
ATLAS is, as far as we know, the largest database on ESCC developed to be a user-friendly web based platform for 
the investigation of molecules to be queried either from the gene, miRNA or protein perspective. To make sure 
the relevance of ESCC ATLAS, we plan to update it annually to facilitate inclusion of new publicly available and 
annotation data. We strongly feel that ESCC ATLAS provides a novel and comprehensive tool for the systematic 
identification of molecular alterations in ESCC, which could be useful for the discovery of novel anticancer drugs 
targeting the ESCC, or for better understanding of the ESCC pathogenesis. All together, ESCC ATLAS is the 
largest database providing a comprehensive view for published data derived from either primary ESCC tissues 
samples or established ESCC cell lines. The data is provided in an easily available platform for the academic and 
not-for-profit organizations when exploring the molecular alterations that underlie ESCC. The current version of 
ESCC ATLAS covers DNA, mRNA, miRNA and protein level alterations. We will continue to review and assess 
the quality of our information and collection of ESCC-related molecular alterations in the future. For future, one 
of our goals is to identify the signal transduction pathway events that have significant impact on ESCC tumori-
genesis and pathophysiology. In parallel, we will also catalog and include the downstream molecules of the altered 
signaling pathway in ESCC to fulfill the requirement towards identification of new drug targets, ESCC genes 
and novel mechanisms. For accelerating the research beyond geographic borders, between basic biomedical and 
clinical research in esophageal cancer, it is of utmost importance to have upcoming clinical and biological data 
on ESCC in a single repository like ESCC ATLAS. Hence we will invite researchers in the field of ESCC to deposit 
their data so that along with them, rest of the world also have access to the recent data on ESCC.
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Data Availability. The data in ESCC ATLAS is freely accessible for academic Institutes/Universities and as 
well as for Not-for-profit organizations at the http://www.esccatlas.org website. All data generated and analyzed 
during our study are included in this published article and its supplementary information file-Dataset 1,2,3 and 4.
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